We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Disparities in Cancer Incidence by Sex and Associated Lifestyle Factors and Health Conditions: An Integrative Review

MedXY Editorial Team•Sep 28, 2026•Clinical Updates
obesitySex Disparitiessmokingepidemiologycancer incidencelifestyle factors

Highlights

  • Sex disparities in cancer incidence are evident globally, with males at higher risk than females.
  • Modifiable lifestyle factors such as smoking, heavy alcohol consumption, and obesity largely explain this disparity in some populations, notably in China.
  • Differences in attributable risk proportions between Chinese and UK cohorts underscore the need for population-specific prevention strategies.
  • Emerging evidence from meta-analyses supports the roles of diabetes, chronic diseases, oral health, and autoimmune conditions as modifiers of cancer risk differing by sex.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Serum GLP-1 as a Novel Biomarker for Endometrial Cancer Detection in Obese WomenThis study reveals that lower serum GLP-1 levels are independently associated with endometrial cancer in obese, non-diabetic women, suggesting its potential as a diagnostic biomarker with high sensitivity and specificity.Oct 3, 2026Challenges in Using Insulin Dose-Adjusted HbA1c to Identify Partial Remission in Pediatric Type 1 Diabetes: Insights from the SEARCH for Diabetes in Youth StudyThis study highlights the limitations of insulin dose-adjusted hemoglobin A1c (IDAA1c) ≤9 in detecting partial remission in US youth with type 1 diabetes, especially those with overweight or obesity, suggesting BMI-specific adjustments imprOct 3, 2026Petrelintide: A Promising Human Amylin Analogue for Long-Term Obesity ManagementPetrelintide, a novel once-weekly human amylin analogue, demonstrates significant bodyweight reduction versus placebo in adults with obesity, with favorable gastrointestinal tolerability, supporting its potential as a long-term obesity therOct 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Positive Pleural Fluid Cultures in ICU Patients: Insights from a Decade-Long Population-Based Study
This comprehensive 10-year ICU study reveals a low prevalence of positive pleural fluid cultures, highlights the significant link to suspected pleural infection, and associates culture positivity with higher 90-day mortality, informing targ
Sep 30, 2026
Unraveling the Predictors of Peak Weight Loss with Semaglutide in Cardiovascular Patients: Insights from the SELECT TrialIn the SELECT trial, baseline clinical factors poorly predicted peak body weight loss with semaglutide, highlighting the role of sex and dosage but underscoring substantial unexplained variability in patient response.Sep 29, 2026
Unraveling the Cardiovascular Benefits of Semaglutide: Insights from the SELECT Trial Mediation AnalysisThe SELECT trial demonstrates semaglutide’s 20% reduction in major cardiovascular events in adults with obesity and cardiovascular disease. Mediation analysis reveals partial but uncertain roles of weight, inflammation, and glycemic mSep 25, 2026